🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on October 14 at 51 years old after a personal fight with pancreatic malignancy.

“The shining star of our household has dimmed his light for us in this life,” his relatives stated. “After a lengthy and courageous battle with cancer, we are heartbroken to announce that D’Angelo, known to his followers around the globe as D’Angelo, has been called home.”

D’Angelo made a lasting impact on music with his innovative neo-soul sound and partnerships with high-profile artists.

He released his first record, “Brown Sugar,” in the mid-nineties to immediate acclaim. The record achieved the fourth spot on the R&B charts, earned platinum status later that year, and earned multiple award nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his music career into the limelight. The album debuted at No. 1 on both the R&B charts and the main album chart. He received two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The personal depiction featured the artist, notably stripped down to his midsection, performing straight into the lens.

D’Angelo retreated from the public eye after releasing Voodoo and publicly struggled with substance abuse. In 2005, he was involved in a serious car crash that put him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with another top chart entry on the soul music rankings and a Grammy for Best R&B Album.

Once more, in his own enigmatic way, D’Angelo had limited public appearances in the following years.

The musician was announced as a top act for the 2025 music event, but his performance was canceled, citing an “unexpected health issue.”

Even though details are sparse about D’Angelo’s health in the months before his passing, he had apparently been hospitalized for months and in hospice for two weeks.

D’Angelo’s passing is a clear example of the harmful impact of pancreatic cancer, one of the most deadly and hardest to prevent forms of the disease, on a gifted artist whose life was cut short.

“We are grieved that he can only leave dear memories with his family, but we are eternally grateful for the legacy of deeply emotional music he leaves behind,” his kin expressed.

Pancreatic Malignancy: Deadly and Difficult to Avoid

Pancreatic malignancy impacts the digestive organ, a tiny gland that generates the hormone insulin and is vital in breaking down food, among additional roles. The size and location of the organ in the body make it more difficult to detect malignancy.

Even though pancreatic cancer makes up only about 3% of malignancy cases each year in the U.S., it is responsible for 7% of malignancy fatalities.

Almost seventy thousand individuals will be diagnosed with pancreatic cancer and about fifty-two thousand will succumb to the disease in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have few and ineffective therapies, and a smaller window to make a significant difference on the lives of patients,” noted a medical oncologist.

Because pancreatic cancer seldom produces early symptoms, it’s often identified only once the condition is advanced. Although a patient has symptoms they are usually vague and may be mistaken for a several common illnesses.

“As of yet, there is no effective method to identify this malignancy in the early stages, except for listening to your body and consulting your doctor if there are new or unusual symptoms,” explained a health expert.

Frequent indicators of this disease encompass:

• abdominal or lower back pain
• weight loss
• jaundice
• loss of appetite
• dark urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At 51 years old, D’Angelo’s death is an outlier, as this malignancy is most common in individuals in the 65 to 75 range. However, many cancers, including pancreatic cancer, have become more common in younger adults.

“This disease identified prior to fifty is considered rare, yet concerningly, clinicians are beginning to see a growing number of younger individuals suffering from this disease,” commented a specialist.

Genetic Background Impacts Disease Probability

Without effective detection methods for this malignancy, experts emphasized the importance of knowing your relatives’ cancer history. Some contributing elements, such as tobacco use and excess weight also play a role in the development of this disease.

Black individuals have the highest incidence of pancreatic cancer in the U.S. and are more prone to be diagnosed with inoperable cancer.

“The initial action toward reducing one’s risk of pancreatic cancer is understanding individual susceptibility. People should review their genetic background, hereditary factors, and medical conditions, such as diabetes, chronic pancreatitis, or obesity that may increase their vulnerability,” said a specialist.

Hereditary elements are linked to as much as 10% of all this malignancy cases. If someone in your family has had this disease, you may want to think about DNA analysis.

“For people with a family history of pancreatic cancer or those carrying high risk DNA changes, screening may involve sophisticated scans such as MRI scans or internal ultrasound to detect early changes in the organ,” he clarified.

For those looking to lower their chance, lifestyle changes may make a difference. The most effective step you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy drinking is linked to pancreatitis, a risk factor for pancreatic cancer, so limiting or avoiding alcohol may help lower your chance.

Controlling your weight or shedding pounds may also aid decrease your susceptibility. Individuals with obesity are 20% more likely to get pancreatic cancer. This malignancy also occurs more often in those with blood sugar issues, and reducing weight can also reduce the risk of adult-onset diabetes.

Despite pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are doing better with therapies and newer mixed drug treatments. There are developing targeted therapies that are already showing results,” remarked a expert.

For many individuals, however, education about this rare but {dev